Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 18;155(6):845-852.
doi: 10.1093/ajcp/aqaa188.

Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations

Affiliations

Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations

Yuxin Liu et al. Am J Clin Pathol. .

Abstract

Objectives: The Lower Anogenital Squamous Terminology (LAST) recommendations classify human papillomavirus-associated squamous lesions into low- and high-grade squamous intraepithelial lesions (LSILs/HSILs). Our study aimed to assess interobserver agreement among 6 experienced pathologists in assigning 40 anal lesions previously diagnosed as anal intraepithelial neoplasia 2 (AIN 2) to either HSIL or non-HSIL categories.

Methods: Agreement based on photomicrographs of H&E alone or H&E plus p16 immunohistochemistry was calculated using κ coefficients.

Results: Agreement was fair based on H&E alone (κ = 0.42; 95% confidence interval [CI], 0.34-0.52). Adding p16 improved agreement to moderate (κ = 0.55; 95% CI, 0.54-0.62). On final diagnosis, 21 cases (53%) had unanimous diagnoses, and 19 (47%) were divided. When designating p16 results as positive or negative, agreement was excellent (κ = 0.92; 95% CI, 0.83-0.95). Among variables (staining location, extent, and intensity), staining of the basal/parabasal layers was a consistent feature in cases with consensus for positive results (20/20). Of the 67 H&E diagnoses with conflicting p16 results, participants modified 32 (48%), downgrading 23 HSILs and upgrading 9 non-HSILs.

Conclusions: Although p16 increased interobserver agreement, disagreement remained considerable regarding intermediate lesions. p16 expression, particularly if negative, can reduce unwarranted HSIL diagnoses and unnecessary treatment.

Keywords: Anal intraepithelial neoplasia 2; Human papillomavirus; Interobserver agreement; p16 Immunohistochemistry.

PubMed Disclaimer

Figures

Image 1
Image 1
Interpretation of p16 immunohistochemistry (IHC) results. A, Case 15 with diffuse, continuous staining of basal and parabasal layers with upward extension. All participants interpreted as positive. Positive to negative: 6:0. B, Case 7 with discontinuous staining throughout the epithelium but not basal and parabasal layers. All participants interpreted as negative. Positive to negative: 0:6. C, Case 9 with focal staining in the basal and parabasal layers. Two participants interpreted as positive, and 4 interpreted as negative. Positive to negative: 2:4. D, Case 13 with patchy staining of the epithelium, including limited basal and parabasal staining. Five participants interpreted as positive, and 1 interpreted as negative. Positive to negative: 5:1. (p16 IHC, original magnification ×100.)
Image 2
Image 2
Impact of p16 immunohistochemistry (IHC) results on final diagnosis. A, Case 28 was diagnosed as high-grade squamous intraepithelial lesion (HSIL) by all 6 participants based on H&E morphology. B, Given the negative p16 result, 4 participants downgraded it to non-HSIL, and 2 maintained the HSIL diagnosis. C, Case 11 was diagnosed as non-HSIL by all 6 participants based on H&E morphology. D, Given the positive p16 result, 3 participants upgraded it to HSIL, whereas 3 maintained the non-HSIL diagnosis. (A and C, H&E, ×200; B and D, p16 IHC, ×200.)
Image 3
Image 3
Lesions originating from anal transitional zone. A, Case 19 was diagnosed as high-grade squamous intraepithelial lesion (HSIL) by 3 participants and non-HSIL by 3 based on H&E morphology. B, Given the positive p16 result, 5 participants diagnosed it as HSIL, and 1 maintained a non-HSIL diagnosis. C, Case 3 was diagnosed as HSIL by 4 and non-HSIL by 2 based on H&E morphology. D, Given the negative p16 result, 5 participants diagnosed it as non-HSIL, whereas 1 maintained HSIL. (A and C, H&E, ×200; B and D, p16 immunohistochemistry, ×100.)

References

    1. Darragh TM, Colgan TJ, Cox JT, et al. . Members of LAST Project Work Groups . The Lower Anogenital Squamous Terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med. 2012;136:1266-1297. - PubMed
    1. Stoler MH. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol. 2000;19:16-28. - PubMed
    1. WHO Classification of Tumours. Lyon, France: International Agency for Research on Cancer; 2019.
    1. Castle PE, Stoler MH, Solomon D, et al. . The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol. 2007;127:805-815. - PubMed
    1. Castle PE. A LASTing impression: incorporating p16 immunohistochemistry into routine diagnosis of cervical neoplasia. Pathol Case Rev. 2013;18:154-157.

Publication types

MeSH terms

Substances